🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06902584
Recruiting Observational

North American Comfilcon A Clinical Study

NCT06902584 · tracked via the Priya Life Science USA tracker
Sponsor
CooperVision International Limited (CVIL)
Phase
Observational
Started
2025-02-05
Last updated
2025-08-27

Condition(s) studied

AstigmatismPresbyopiaAmetropia

Investigational drug(s) / intervention(s)

comfilcon A Sphere lenscomfilcon A Toric lenscomfilcon A Multifocal lenscomfilcon A Multifocal Toric lenscomfilcon A Energys lens

comfilcon A Sphere lens: 2 hours of wear

comfilcon A Toric lens: 2 hours of wear

comfilcon A Multifocal lens: 2 hours of wear

comfilcon A Multifocal Toric lens: 2 hours of wear

comfilcon A Energys lens: 2 hours of wear

Study summary

The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.

Eligibility

Sex
ALL
Min age
8 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age 8 to 75 years (inclusive). 2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months. 3. At least occasional overnight wear in the last 12 months. Exclusion Criteria: 1\. Current participation in a contact lens or contact lens care product clinical trial.

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
University of Berkeley Berkeley California Recruiting
ProCare Vision Center Granville Ohio Recruiting
Nittany Eye Associates College Pennsylvania Recruiting
Drs. McIntyre, Garza, Avila and Jurica, Optometrists Corpus Christi Texas Recruiting

More CooperVision International Limited (CVIL) trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06902584 on ClinicalTrials.gov ↗ ← All trials in the USA